More than 200 leading CEOs will gather at the 2012 CEO Conference June 11th and 12th at the Mandarin Oriental Hotel in Boston.
The Boston CEO Conference is a forum for industry CEOs and decision makers in the life sciences. Attendees gain insights from presentations and panels featuring CEOs from several of the world's leading biopharmaceutical companies. Industry leaders in venture capital, strategic consulting and private equity also participate.
Conference co-hosts include: Rich Aldrich, Marc Beer, Harvey Berger, Josh Boger, Tony Coles, Michelle Dipp, Deborah Dunsire, Jens Eckstein, Doug Fambrough, Ansbert Gadicke, Jim Greenwood, Sylvie Gregoire, Tuan Ha-Ngoc, Peter Hecht, Jeff Leiden, Mark Levin, John Maraganore, Lonnie Moulder, Richard Pops, Mike Powell, George Scangos, Henri Termeer, Peter Thompson, and Christoph Westphal.
"This is an important gathering of the brightest CEOs in biotech," said Henri Termeer, former Chairman & CEO, Genzyme.
"This meeting is an opportunity for CEOs to gather and discuss matters that are pertinent to our industry and to making biotech businesses thrive," said Richard Pops, Chairman and CEO of Alkermes plc.
The agenda features several luminaries in medicine and research, as well as executives of the next generation of leading biotech and pharma companies. For more information or to register for the conference, visit https://www.bbbiotechconference.com/register.php?id=11.
Contacts:
Pure Communications
Katie Wilson, 910-509-3977
katie@purecommunicationsinc.com
